Cargando…

Phenotyping of Sleep‐Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction—the SchlaHF Registry

BACKGROUND: Different sleep‐disordered breathing (SDB) phenotypes, including coexisting obstructive and central sleep apnea (OSA‐CSA), have not yet been characterized in a large sample of patients with heart failure and reduced ejection fraction (HFrEF) receiving guideline‐based therapies. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arzt, Michael, Oldenburg, Olaf, Graml, Andrea, Erdmann, Erland, Teschler, Helmut, Wegscheider, Karl, Suling, Anna, Woehrle, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778994/ https://www.ncbi.nlm.nih.gov/pubmed/29187390 http://dx.doi.org/10.1161/JAHA.116.005899

Ejemplares similares

Prevalence and predictors of sleep‐disordered breathing in chronic heart failure: the SchlaHF‐XT registry
por: Arzt, Michael, et al.
Publicado: (2022)

Determining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA-HF registry
por: Woehrle, Holger, et al.
Publicado: (2014)

Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure
por: Cowie, Martin R., et al.
Publicado: (2013)

Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis
por: Woehrle, Holger, et al.
Publicado: (2017)

Predictors of positive airway pressure therapy termination in the first year: analysis of big data from a German homecare provider
por: Woehrle, Holger, et al.
Publicado: (2018)

Telemedicine-based proactive patient management during positive airway pressure therapy: Impact on therapy termination rate
por: Woehrle, Holger, et al.
Publicado: (2017)

Effect of adaptive servo ventilation on central sleep apnea and sleep structure in systolic heart failure patients: polysomnography data from the SERVE‐HF major sub study
por: Tamisier, Renaud, et al.
Publicado: (2022)

Effects of Adaptive Servo-Ventilation on Nocturnal Ventricular Arrhythmia in Heart Failure Patients With Reduced Ejection Fraction and Central Sleep Apnea–An Analysis From the SERVE-HF Major Substudy
por: Fisser, Christoph, et al.
Publicado: (2022)

Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE‐HF trial
por: Ferreira, João Pedro, et al.
Publicado: (2020)

Methodology for the nocturnal cardiac arrhythmia ancillary study of the ADVENT-HF trial in patients with heart failure with reduced ejection fraction and sleep-disordered breathing
por: Horvath, Christian M., et al.
Publicado: (2022)

Registry on the Treatment of Central and Complex Sleep-Disordered Breathing with Adaptive Servo-Ventilation (READ-ASV): protocol and cohort profile
por: Arzt, Michael, et al.
Publicado: (2023)

Ventricular arrhythmia in heart failure patients with reduced ejection fraction and central sleep apnoea
por: Fisser, Christoph, et al.
Publicado: (2021)

Insights into the Interaction of Heart Failure with Preserved Ejection Fraction and Sleep-Disordered Breathing
por: Wester, Michael, et al.
Publicado: (2023)

Effect of adaptive servo-ventilation for central sleep apnoea in systolic heart failure on muscle sympathetic nerve activity: a SERVE-HF randomised ancillary study
por: Tamisier, Renaud, et al.
Publicado: (2023)

Sleep-disordered breathing in patients with newly diagnosed lung cancer
por: Dreher, Michael, et al.
Publicado: (2018)

Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry)
por: Jin, Xuejuan, et al.
Publicado: (2019)

Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN‐HF Registry
Publicado: (2020)

Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN‐HF Registry
por: MacDonald, Michael R., et al.
Publicado: (2019)

Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry
por: Uijl, A., et al.
Publicado: (2021)

Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional Analysis
por: Vijay, Aishwarya, et al.
Publicado: (2023)

Prevalence Of Chronic Hypercapnia In Severe Chronic Obstructive Pulmonary Disease: Data From The HOmeVent Registry
por: Dreher, Michael, et al.
Publicado: (2019)

Female Patients With Sleep-Disordered Breathing Display More Frequently Heart Failure With Preserved Ejection Fraction
por: Lebek, Simon, et al.
Publicado: (2021)

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022)

The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2020)

Mask humidity during CPAP: influence of ambient temperature, heated humidification and heated tubing
por: Nilius, Georg, et al.
Publicado: (2018)

Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
por: Jackson, Alice M., et al.
Publicado: (2020)

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF
por: Docherty, Kieran F., et al.
Publicado: (2022)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: Abboud, Andrew, et al.
Publicado: (2021)

Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
por: Choi, Ki Hong, et al.
Publicado: (2018)

Representativeness of the GALACTIC‐HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction
por: Mefford, Matthew T., et al.
Publicado: (2022)

Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF
por: Adamson, Carly, et al.
Publicado: (2022)

Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF
por: Butt, Jawad H., et al.
Publicado: (2021)

Automatic positive airway pressure for obstructive sleep apnea in heart failure with reduced ejection fraction
por: Fox, Henrik, et al.
Publicado: (2020)

Clinical characteristics and outcomes of black African heart failure patients with preserved, mid‐range, and reduced ejection fraction: a post hoc analysis of the THESUS‐HF registry
por: Dzudie, Anastase, et al.
Publicado: (2020)

Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction
por: Cannon, Jane A., et al.
Publicado: (2016)

Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
por: Jensen, Jesper, et al.
Publicado: (2019)

Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
por: Polito, Maria Vincenza, et al.
Publicado: (2020)

Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS‐HF
por: Fudim, Marat, et al.
Publicado: (2020)

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
por: Jhund, Pardeep S., et al.
Publicado: (2021)

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
por: Lund, Lars H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g8ddj4on9aac8m57djrkrm3ama